Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
By B. Müller, K. Becker, Hartmut Schächinger, P. Rickenbacher, P. Huber, W. Zimmerli, R. Ritz. Critical Care Medicine, 2000
638 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology
View Paper: https://www.semanticscholar.org/paper/0160e0ca2da056782b17f3549630d20dff1b2f4b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- B. Uzzan
- R. Cohen
- C. Müller
- D. Miedinger
- P. Nicolas
- R. Bingisser
- Michel Cucherat
- P. Huber
Citations in the corpus
- Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. (2006, background): “For this purpose it is more helpful than CRP and other laboratory markers (17, 32).”
- Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. (2004, neutral): “[119] 103/3 9/40 97 (91–99) 82 (68–91) 73/0 37/43 100 (95–100) 54 (42–65) Muller [121] 52/3 6/40 95 (84–99) 87 (73–95) 41/9 17/34 82 (68–91) 67 (52–79) Penel et al.”
- Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis (2006, methodology): “Q* value for CRP 0.71; 95% CI, 0.64–0.76; corrected p .02, computed under the conservative hypothesis of a .5 correlation coefficient between PCT and CRP values).”